Diadema Partners »

Proqr Thrapeutics N V shs euro shares owned by Diadema Partners

Quarter-by-quarter ownership of Proqr Thrapeutics N V shs euro (PRQR) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Proqr Thrapeutics N V shs euro

Tip: Access up to 7 years of quarterly data

All positions including Proqr Thrapeutics N V shs euro held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Proqr Thrapeutics N V shs euro by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $336k 158k 2.13

More positions owned by Diadema Partners

Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)
Uniqure Nv SHS Put Option (QURE)
Regeneron Pharmaceuticals (REGN)
Viking Therapeutics (VKTX)
Bristol Myers Squibb (BMY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
BioMarin Pharmaceutical (BMRN)
Avidity Biosciences Ord (RNA)
Agios Pharmaceuticals Call Option (AGIO)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation Call Option (INCY)
Intellia Therapeutics Call Option (NTLA)
Vaxcyte (PCVX)
Eli Lilly & Co. Put Option (LLY)

View all positions for Diadema Partners

Top funds holding Proqr Thrapeutics N V shs euro

Adage Capital Partners GP
Privium Fund Management B.V.
Affinity Asset Advisors
Morgan Stanley
Standard Life Aberdeen
Sio Capital Management
Kynam Capital Management
DAFNA Capital Management
Siren
Arrowpoint Asset Management
Platinum Investment Mangement
M28 Capital Management
Ikarian Capital
Point72 Asset Management
Citadel Advisors

View all funds holding Proqr Thrapeutics N V shs euro